Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris

British Journal of Dermatology

Volumn 140, Issue 6, 1999, Pages 1079-1086

  Rico, M J ^a   Benning, C ^a   Weingart, E S ^a   Streilein, R D ^b   Hall III, R P ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bullous pemphigoid; Cytokines; Immunohistochemistry; Interleukin 5; Pemphigus vulgaris; Th1 cells; Vascular cell adhesion molecule 1

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PATHOGENESIS; PEMPHIGOID; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN INFILTRATE;

BIOLOGICAL MARKERS; CELL ADHESION; CELLS, CULTURED; CYTOKINES; EOSINOPHILS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; PEMPHIGOID, BULLOUS; PEMPHIGUS; RNA, MESSENGER; SKIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032983886     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02907.x     Document Type: Article

References (34)

1. 1 Caproni M, Feliciani C, Fuligni A et al. Th2-like cytokine activity in dermatitis herpetiformis. Br J Dermatol 1998; 138: 242-7.
2. 2 Endo H, Iwamoto I, Fujita M et al. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid. Arch Dermatol Res 1992; 284: 312-14.
3. 3 Guesdon J, Ternynck T, Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979; 27: 1131-9.
4. 4 Bromley L, McCarthy SP, Stickland JE et al. Non-isotopic in situ detection of mRNA for interleukin-4 in archival human tissue. J Immunol Methods 1995; 167: 47-54.
5. 5 Woodroofe MN, Li H, Newcombe J, Cuzner ML. Detection of cytokine mRNAs in multiple sclerosis brain tissue by in-situ hybridization. Int J Exp Pathol 1992; 73: A22 (Abstr.).
6. 6 Schleimer RP, Sterbinsky SA, Kaiser J et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. J Immunol 1994; 148: 1086-92.
7. 7 Gammon WR, Merritt CC, Lewis DM et al. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol 1982; 78: 285-9.
8. 8 Schaller J, Haustein U, Fiebig H. T-helper cell activation in bullous pemphigoid. Acta Derm Venereol (Stockh) 1987; 67: 520-3.
9. 9 Michalaki H, Nicolas JF, Kanitakis J. T cells in bullous pemphigoid. Presence of activated CD4+ cells at the basement membrane zone in pre and peribullous skin. Regional Immunol 1991; 3: 151-5.
10. 10 Hunyadi J, Dobozy A, Keneressy AS. Evidence for cell-mediated autoimmunity in patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol Res 1979; 265: 9-14.
11. 11 Kaneko F, Minagawa T, Takiguchi Y et al. Role of cell-mediated immune reaction in blister formation of bullous pemphigoid. Dermatologica 1992; 184: 34-9.
12. 12 Jahnsen FL, Brandtzaeg P, Halstensen TS. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated cosinophils. J Immunol Methods 1994; 175: 23-36.
13. 13 Ying S, Meng Q, Barata LT et al. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of cosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol 1997; 158: 5050-7.
14. 14 Zhang J, Markovic-Plese S, Lacet B et al. Increased frequency of interleukin 2-responsive T cells specific for myclin basic protein and proteolipid in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179: 973-84.
15. 15 Stein LF, Saed GM, Fivenson DP. T-cell cytokine network in cutaneous lupus erythematosus. J Am Acad Dermatol 1997; 37: 191-6.
16. 16 Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227-57.
17. 17 Kay AB, Ying S, Varney V et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor in allergen-induced late phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173: 775-8.
18. 18 Tanaka Y, Delapote E, Dubacquoi S et al. Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin. J Invest Dermatol 1994; 103: 589-92.
19. 19 Vowels BR, Lessin SR, Cassin M et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 1994; 103: 669-73.
20. 20 Wucherpfenning KW, Yu B, Bhol K et al. Structural basis for major histocompatibility complex (MHC) -linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci USA 1995; 92: 11935-9.
21. 21 Lin M, Swartz SJ, Lopez A et al. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest 1997; 99: 31-40.
22. 22 Hertl M, Amagai M, Sundaram H et al. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals. J Invest Dermatol 1998; 110: 388-92.
23. 23 Taguchi T, McGhee JR, Coffman RL et al. Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J Immunol Methods 1990; 128: 65-73.
24. 24 Ying S, Humbert M, Barkans J et al. Expression of IL-4 and IL-5 mRNA protein product CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997; 158: 3539-44.
25. 25 Goldstein SM, Wasserman SI, Wintroub BU. Mast cell and eosinophil mediated damage in bullous pemphigoid. Immunol Ser 1989; 46: 527-45.
26. 26 Burd PR, Thompson WC, Max EE, Mills FC. Activated mast cells produce interleukin 13. J Exp Med 1995; 181: 1373-80.
27. 27 Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867-9.
28. 28 Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 1993; 14: 111-15.
29. 29 O'Toole EA, Arami S, Guitart J et al. Eotaxin, an eosinophil-specific chemoattractant, is upregulated in bullous pemphigoid lesional epidermis and in normal human keratinocytes stimulated by a pro-inflammatory cytokine IL-1α. J Invest Dermatol 1997; 108: 546 (Abstr.).
30. 30 Okada S, Kita H, George TJ et al. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. Am J Respir Cell Mol Biol 1997; 16: 455-63.
31. 31 Mochizuki M, Bartels J, Mallet Al et al. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998; 160: 60-8.
32. 32 Mahanty S, Nutman TB. The biology of interleukin-5 and its receptor. Cancer Invest 1993; 11: 624-34.
33. 33 Stahle-Backdahl M, Inoue M, Giudice GJ, Parks WC. 92 kD gelatinase is produced by cosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180 kD bullous pemphigoid autoantigen. J Clin Invest 1994; 93: 2022-30.
34. 34 Czech W, Schaller J, Schopf E, Kapp A. Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris. J Am Acad Dermatol 1993; 29: 210-15.